JP Morgan Chase
IART icon

JP Morgan Chase’s Integra LifeSciences IART Stock Holding History

JP Morgan Chase’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-84,400
Closed -$4.7M – 5864
2019
Q1 		$4.7M Buy
+84,400
New +$4.3M ﹤0.01% 2632

Other funds holding IART

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

JP Morgan Chase's IART Position: Q1 2026 in Review

JP Morgan Chase reduced its Integra LifeSciences (IART) stake by 25% in Q1 2026, selling an estimated $1.41M and leaving 392,468 shares worth $3.58M. The position accounts for ﹤0.01% of the portfolio, ranked #3627.

JP Morgan Chase first reported a position in IART in Q2 2013 and has held it in 49 quarters since. The position peaked at $18.3M in Q3 2018. 202 funds tracked by Wall St. Rank hold IART as of Q1 2026.

  • JP Morgan Chase held 392,468 shares of Integra LifeSciences worth $3.58M as of Q1 2026.
  • JP Morgan Chase sold 128,645 Integra LifeSciences shares in Q1 2026, an estimated $1.41M.
  • Integra LifeSciences made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #3627 holding.
  • JP Morgan Chase first reported a position in Integra LifeSciences in Q2 2013 and has held it in 49 quarters since.
  • JP Morgan Chase's Integra LifeSciences position peaked at $18.3M in Q3 2018.
  • 202 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.